Which serologic marker is present in individuals vaccinated against Hepatitis B?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $9.99Unlock all

Prepare for the COMLEX Level 2 Exam with an array of challenging multiple-choice questions designed to enhance understanding. Each question includes detailed explanations and hints to facilitate learning. Equip yourself with the knowledge necessary to excel in your osteopathic medical career.

Multiple Choice

Which serologic marker is present in individuals vaccinated against Hepatitis B?

Explanation:
Individuals vaccinated against Hepatitis B will have the presence of anti-HB surface IgG in their serologic profile. This immunoglobulin is the result of the immune system generating an antibody response following vaccination with the Hepatitis B surface antigen (HBsAg). The vaccine contains purified HBsAg that stimulates the body to produce antibodies without causing the disease. The presence of anti-HB surface IgG indicates that the individual has successfully developed immunity against Hepatitis B, providing protection from future infections. In contrast, the HB surface antigen indicates an active Hepatitis B infection, while anti-HB core IgM typically appears during acute infections. HB e antigen is also associated with active viral replication and is not a marker for vaccination. Hence, the presence of anti-HB surface IgG is the hallmark of successful vaccination and immunity to Hepatitis B.

Individuals vaccinated against Hepatitis B will have the presence of anti-HB surface IgG in their serologic profile. This immunoglobulin is the result of the immune system generating an antibody response following vaccination with the Hepatitis B surface antigen (HBsAg).

The vaccine contains purified HBsAg that stimulates the body to produce antibodies without causing the disease. The presence of anti-HB surface IgG indicates that the individual has successfully developed immunity against Hepatitis B, providing protection from future infections.

In contrast, the HB surface antigen indicates an active Hepatitis B infection, while anti-HB core IgM typically appears during acute infections. HB e antigen is also associated with active viral replication and is not a marker for vaccination. Hence, the presence of anti-HB surface IgG is the hallmark of successful vaccination and immunity to Hepatitis B.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy